AVALLONE, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.227
EU - Europa 481
AS - Asia 366
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 2
Totale 2.103
Nazione #
US - Stati Uniti d'America 1.221
SG - Singapore 241
IT - Italia 198
IE - Irlanda 108
SE - Svezia 73
CN - Cina 71
DE - Germania 27
NG - Nigeria 18
FR - Francia 16
IN - India 16
FI - Finlandia 11
JP - Giappone 9
UA - Ucraina 8
ID - Indonesia 7
KR - Corea 7
NL - Olanda 7
BE - Belgio 6
EU - Europa 5
MY - Malesia 5
CA - Canada 4
GB - Regno Unito 4
IR - Iran 4
BR - Brasile 3
CH - Svizzera 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
NO - Norvegia 2
PK - Pakistan 2
PL - Polonia 2
RS - Serbia 2
RU - Federazione Russa 2
SI - Slovenia 2
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
MK - Macedonia 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.103
Città #
Chandler 340
Singapore 212
Dublin 108
Ashburn 79
Santa Clara 73
Nyköping 57
Columbus 55
Turin 49
Princeton 32
Medford 29
Milan 27
Abuja 18
Boston 17
Hebei 16
Fairfield 15
Beijing 13
Guangzhou 13
New York 12
Pune 12
Torino 12
Washington 10
Chengdu 7
Hangzhou 7
Helsinki 7
Ann Arbor 6
Bari 6
Brussels 6
Jakarta 6
Seattle 6
Seoul 6
Wilmington 6
Norwalk 5
Cambridge 4
Hamburg 4
Lappeenranta 4
Los Angeles 4
Mountain View 4
Munich 4
Parma 4
Woodbridge 4
Castiglione Olona 3
Catania 3
Guiyang 3
Huskvarna 3
Pescara 3
Redmond 3
Rome 3
San Diego 3
Toronto 3
Valmacca 3
Antioch 2
Arezzo 2
Belgrade 2
Berlin 2
Biella 2
Esslingen am Neckar 2
Gdansk 2
Gjettum 2
Gornji Stupnik 2
Houston 2
Karachi 2
Kuala Lumpur 2
La Paz 2
Lausanne 2
Ljubljana 2
London 2
L’Aquila 2
Modena 2
Mogliano Veneto 2
Naples 2
Novara 2
Padova 2
Perugia 2
Putrajaya 2
Redwood City 2
Schwerin 2
Torgiano 2
Torre Pellice 2
Atlanta 1
Baricella 1
Bologna 1
Bourne 1
Cape Coral 1
Casagiove 1
Caselle Torinese 1
Castel San Pietro Terme 1
Cattolica 1
Chennai 1
Chioggia 1
Clearwater 1
Cologne 1
Denizli 1
Eitensheim 1
Fagnano Olona 1
Falls Church 1
Frankfurt am Main 1
Frederick 1
Gainesville 1
Genova 1
Gunzenhausen 1
Totale 1.407
Nome #
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 127
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 82
Immunotherapy in transplanted patients: A special population that can no longer be ignored 75
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 65
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report 62
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 61
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 58
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients 57
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study 56
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 56
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 54
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 54
Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications 52
Reply to ‘The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al 52
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 51
Tocilizumab and its usage for skin diseases 49
Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related? 49
Dupilumab in HIV-positive patients with atopic dermatitis: A long-term follow-up patient and a literature review 49
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 48
Ruta graveolens phytophotodermatìtis 48
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association 46
Microenvironment in cutaneous melanomas: a gene expression profile study may explain the role of histological regression 44
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 44
Risankizumab shows high efficacy and maintenance in improvement of response until week 52 44
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study 43
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System 41
Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature 40
Dupilumab-induced Urticaria 39
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis 37
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma 36
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy 36
Clinical outcomes and management of JAK inhibitor-associated acne (JAKne) in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study 32
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review 32
Regression of human papillomavirus-associated high-grade vaginal intraepithelial neoplasia after switching from ustekinumab to risankizumab in a psoriasis patient 30
Non-sentinel lymph node detection during sentinel lymph node biopsy in not-complete-lymph-node- dissection era: A new technique for better staging and treating melanoma patients 30
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 28
Perspectives of immunotherapy in non-melanoma skin cancers 26
Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lata 25
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy 23
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents 23
Attitudes, characteristics, and occupational-related risk of skin cancer and cutaneous melanoma in the militaries: an observational, cross-sectional, survey-based study 21
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association 20
Lichen ruber planus arising during dupilumab treatment for atopic dermatitis 20
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis 19
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study 17
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: A novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome 16
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin 16
Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience 14
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course 14
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 14
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study 13
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks 13
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study 12
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center 12
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals 12
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic 11
Mixed purpuric and maculopapular eruption in a 70-year-old woman 11
Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres 7
Maculopapular rash: An overlooked monkeypox diagnostic clue? 7
Topical ruxolitinib: A new treatment for vitiligo 6
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? 4
Rechallenge and retreatment with topical imiquimod 5% in transplant recipients: A multicenter experience on actinic keratoses and basal cell carcinomas 4
Dramatic progression of multifocal primary cutaneous anaplastic large-cell lymphoma 3
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 3
‘Poroma-like’ branched vessels with rounded endings in dermoscopy of basal cell carcinoma: a new unusual structure 2
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini‐melanoma): a retrospective multicentric study of 269 cases 2
Clinical and Histopathological Findings in Palmoplantar Lichen Planus Presenting as Diffuse Keratoderma 2
Totale 2.199
Categoria #
all - tutte 12.345
article - articoli 0
book - libri 0
conference - conferenze 460
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 1 1 0 0 0 0 0 2 5
2021/2022381 36 7 7 14 48 18 14 10 19 20 61 127
2022/2023818 67 114 19 72 74 153 51 79 73 13 64 39
2023/2024479 54 83 37 38 24 88 6 33 6 34 21 55
2024/2025512 19 119 44 117 213 0 0 0 0 0 0 0
Totale 2.199